246 related articles for article (PubMed ID: 15661064)
1. Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis.
Ishii Y; Itoh N; Takahashi A; Masumori N; Ikeda T; Tsukamoto T
Int J Urol; 2005 Jan; 12(1):104-7. PubMed ID: 15661064
[TBL] [Abstract][Full Text] [Related]
2. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
[TBL] [Abstract][Full Text] [Related]
3. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
[TBL] [Abstract][Full Text] [Related]
4. Jejunal adenocarcinoma presenting as a primary ovarian carcinoma.
Kilic G; Abadi M
Gynecol Oncol; 2000 Aug; 78(2):255-8. PubMed ID: 10926813
[TBL] [Abstract][Full Text] [Related]
5. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
Chu P; Wu E; Weiss LM
Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
[TBL] [Abstract][Full Text] [Related]
7. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
Park SY; Kim HS; Hong EK; Kim WH
Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.
Jiang J; Ulbright TM; Younger C; Sanchez K; Bostwick DG; Koch MO; Eble JN; Cheng L
Arch Pathol Lab Med; 2001 Jul; 125(7):921-3. PubMed ID: 11419977
[TBL] [Abstract][Full Text] [Related]
9. The androgen receptor revisited in urothelial carcinoma.
Birtle AJ; Freeman A; Munson P
Histopathology; 2004 Jul; 45(1):98-9. PubMed ID: 15228457
[No Abstract] [Full Text] [Related]
10. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
[TBL] [Abstract][Full Text] [Related]
11. Krukenberg tumor of renal pelvic origin: report of a case with selected comments on ovarian tumors metastatic from the urinary tract.
Irving JA; Vasques DR; McGuinness TB; Young RH
Int J Gynecol Pathol; 2006 Apr; 25(2):147-50. PubMed ID: 16633063
[TBL] [Abstract][Full Text] [Related]
12. Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder.
Takehara K; Nomata K; Eguchi J; Hisamatsu H; Maruta S; Hayashi T; Koga S; Kanetake H
Int J Urol; 2004 Nov; 11(11):1016-8. PubMed ID: 15509208
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor.
Han AC; Duszak R
Cancer; 1999 Dec; 86(11):2327-30. PubMed ID: 10590374
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytokeratins 7 and 20 in ovarian neoplasia.
Cathro HP; Stoler MH
Am J Clin Pathol; 2002 Jun; 117(6):944-51. PubMed ID: 12047147
[TBL] [Abstract][Full Text] [Related]
15. Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.
Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Inoue Y; Noguchi H; Honda N
Oncol Rep; 2007 Jul; 18(1):3-7. PubMed ID: 17549338
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma.
Baldwin L; Lee AH; Al-Talib RK; Theaker JM
Histopathology; 2005 Jan; 46(1):50-6. PubMed ID: 15656886
[TBL] [Abstract][Full Text] [Related]
17. [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].
Cid Mouteira P; Ortíz Rey JA; Antón Badiola I; San Miguel Fraile P; Alvarez Alvarez C; Zungri Telo E; de la Fuente Buceta A
Actas Urol Esp; 2002 Apr; 26(4):279-84. PubMed ID: 12090187
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of keratin proteins in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Fukui S; Mori M
Pathol Res Pract; 1989 Feb; 184(2):194-201. PubMed ID: 2469067
[TBL] [Abstract][Full Text] [Related]
20. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
